Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

Liquidia Technologies, Inc.

Contributing Author

Recent Articles by Liquidia Technologies, Inc.

Aug-12
Liquidia Corporation Reports Second Quarter 2026 Financial Results LQDA -10.52% GlobeNewswire
Jul-29
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026 LQDA GlobeNewswire
Jun-11
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions LQDA +9.77% GlobeNewswire
Jun-08
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600 Index LQDA GlobeNewswire
May-27
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference LQDA GlobeNewswire
May-11
Liquidia Corporation Reports First Quarter 2026 Financial Results LQDA +25.60% GlobeNewswire
May-06
Liquidia Corporation to Participate in Upcoming Investor Conferences LQDA +5.01% GlobeNewswire
May-04
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026 LQDA GlobeNewswire
Apr-07
Liquidia Corporation to Participate in Upcoming Investor Conferences LQDA GlobeNewswire
Mar-05
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update LQDA GlobeNewswire
Feb-26
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 LQDA GlobeNewswire
Jan-27
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress LQDA GlobeNewswire
Jan-09
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update LQDA +12.91% GlobeNewswire
Jan-07
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference LQDA GlobeNewswire
Nov-03
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences LQDA GlobeNewswire
Nov-03
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update LQDA GlobeNewswire
Oct-27
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 LQDA GlobeNewswire
Oct-07
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 LQDA +5.10% GlobeNewswire
Sep-29
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting LQDA GlobeNewswire
Sep-11
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium LQDA GlobeNewswire
Aug-27
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference LQDA GlobeNewswire
Aug-12
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update LQDA +13.68% GlobeNewswire
Aug-05
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 LQDA GlobeNewswire
Jun-23
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA LQDA GlobeNewswire
Jun-02
Liquidia Schedules First Commercial Shipment of YUTREPIA (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD LQDA +13.07% GlobeNewswire
May-28
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference LQDA -9.13% GlobeNewswire
May-23
U.S. FDA Approves Liquidia's YUTREPIA (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) LQDA GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)